ISSN 2149-2263 | E-ISSN 2149-2271
pdf
Use of Implantable Cardioverter Defibrillators in the Secondary Prevention of Malignant Ventricular Arrhythmias: What we Have Learned From Large Studies [Anatol J Cardiol]
Anatol J Cardiol. 2001; 1(1): 43-47

Use of Implantable Cardioverter Defibrillators in the Secondary Prevention of Malignant Ventricular Arrhythmias: What we Have Learned From Large Studies

The efficacy of implantable cardioverter defibrillator (ICD) therapy and medical therapy in the treatment of patients with ventricular fibrillation and sustained ventricular tachycardia had been compared in large randomized studies. In this section, we aimed to summarize what we have learned from large studies on the effects of amiodarone and ICD therapy in prevention of cardiac arrest n patients with malignant ventricular arrhythmias. The analyzed studies are; The Multicenter Unsustained Tachycardia Trial (MUSTT), Antiarrhythmics vs. Implantable Defibrillator (AVID), Cardiac Arrest Stduy Hamburg (CASH) and the Canadian Implantable Defibrillator Stduy (CIDS).

Keywords: İmplantable cardioverter defibrillator, malign ventrikül aritmileri, sekonder korunma

. Use of Implantable Cardioverter Defibrillators in the Secondary Prevention of Malignant Ventricular Arrhythmias: What we Have Learned From Large Studies. Anatol J Cardiol. 2001; 1(1): 43-47
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.